How big is the MMR vaccine market | Market Leaders & Share Analysis

Code: MTA7363 Publication Date: Aug 2025

What is the size of MMR Vaccine Market?

According to 6Wresearch internal database and industry insights, the MMR (Measles, Mumps, and Rubella) Vaccine Market was valued at USD 3.8 Billion in 2024 and is projected to reach USD 5.3 Billion by 2031, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period.

Rising worldwide immunization campaigns, rising birth rates in developing nations, and the development of public healthcare infrastructure are the main drivers of this growth. In addition, ongoing research and development efforts and the introduction of combination vaccines are further enhancing market and accessibility.

Key Growth Drivers of the MMR Vaccine Market

  • Expanding government vaccination programs and education campaigns
  • More funding from international health organizations for childhood immunizations
  • Growing populations in underdeveloped countries with improved access to medical care
  • Combination vaccines are in high demand in order to reduce costs and administration time
  • Vaccine availability in remote areas is increased by better cold chain logistics
  • Developments in vaccine formulation and delivery technologies

MMR Vaccine Market Trends

The MMR Vaccine Market is witnessing increased adoption of needle-free and intranasal vaccine delivery. Healthcare providers prefer combination vaccines because they are easier to use and have higher compliance rates. Pharmaceutical companies are focusing on developing thermostable vaccine formulations to address storage challenges in developing nations. Public-private partnerships are enhancing vaccine affordability and coverage. The Asia-Pacific region is emerging as the fastest-growing market due to favorable government policies and population growth.

Emerging Developments in the MMR Vaccine Market

Companies are investing in next-generation MMR vaccines with improved safety profiles and longer-lasting immunity. Single-dose, pre-filled syringes are gaining popularity for ease of administration. International health organizations are promoting adult MMR vaccinations, particularly for travelers and healthcare workers. Digital vaccine tracking systems and mobile immunization units are improving recordkeeping and delivery efficiency in remote areas.

List of Leading Companies in the MMR Vaccine Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. Merck & Co., Inc.

Company NameMerck & Co., Inc.
Established Year1891
HeadquartersNew Jersey, United States
Official WebsiteClick Here

Manufactures the M-M-R® II vaccine, a widely used MMR vaccine approved for use in children and adults worldwide.

2. GlaxoSmithKline plc (GSK)

Company NameGlaxoSmithKline plc (GSK)
Established Year2000
HeadquartersLondon, United Kingdom
Official WebsiteClick Here

This company produces Priorix™, an MMR vaccine used worldwide as part of national immunization programs across various countries.

3. Sanofi Pasteur

Company NameSanofi Pasteur
Established Year2004
HeadquartersLyon, France
Official WebsiteClick Here

This company is involved in developing and supplying a wide portfolio of pediatric vaccines, including MMR, to worldwide markets.

4. Biovac Institute

Company NameBiovac Institute
Established Year2003
HeadquartersCape Town, South Africa
Official WebsiteClick Here

This company partners with worldwide manufacturers to supply vaccines, including MMR, across the African continent through public health networks.

5. AJ Vaccines

Company NameAJ Vaccines
Established Year2017
HeadquartersCopenhagen, Denmark
Official WebsiteClick Here

This company offers childhood immunization vaccines, including MMR, to both private and public healthcare systems internationally.

6. Poonawalla Fincorp (through Bilthoven Biologicals)

Company NamePoonawalla Fincorp (through Bilthoven Biologicals)
Established Year2012
HeadquartersUtrecht, Netherlands
Official WebsiteClick Here

This company supplies MMR vaccines across European and developing markets through technology partnerships and R&D.

How big is the MMR vaccine market : FAQs

The MMR vaccine market is projected to reach USD 5.3 billion by 2031.
The MMR vaccine market is growing at a CAGR of 4.8% during the forecast period from 2025 to 2031.
Infants and children under national immunization programs, along with travelers and healthcare workers, are major consumers.
The innovations include digital tracking for immunization coverage and single-dose formats.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All